Dr. Nazanin Azadi, MD

Dr. Azadi practices at Providence Little Company of Mary Medical Center San Pedro in San Pedro, California, part of Providence Health & Services.

Dr. Azadi's NPI, 1558595082, was assigned on May 12, 2009. Dr. Azadi graduated from VCU School of Medicine in 2007. Dr. Azadi holds California license A107597.

Dr. Azadi's primary practice is Providence Little Company of Mary Medical Center San Pedro, at 1300 W 7th St, San Pedro, CA 90732 in Los Angeles County. The practice phone is (310) 832-3311.

Dr. Azadi's primary practice is Providence Little Company of Mary Medical Center San Pedro in San Pedro, California, part of Providence Health & Services. Dr. Azadi is also affiliated with Torrance Memorial Medical Center. The medical group on file is Providence Medical Institute. Dmand AI also links Dr. Azadi to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azadi practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Azadi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Azadi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Azadi is licensed in California.

Dmand AI lists angioplasty, cardiac catheterization, endocarditis, leg revascularization and varicose vein treatment among the conditions Dr. Azadi treats.

CMS data shows 3,088 Medicare services from Dr. Azadi across 22 procedure codes in 2024, for 1,188 Medicare patients. Medicare paid $185,947 for them.

CMS counts 1,188 Medicare patients who saw Dr. Azadi in 2024. The largest group is 75 to 84, with 441 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Azadi's median patient age at 62, with 55% women.

In 2024, Dr. Azadi wrote 2,891 Medicare Part D claims for 468 patients. 82% of them were for generic drugs. CMS names the drug for 2,625 of them, across 41 drugs with 11 or more claims each, at $527,921 in total drug cost. In 2023, CMS named 2,986 claims across 47 drugs.

Dr. Azadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Azadi as offering telehealth. CMS counts 23 procedures of coronary angioplasty and stenting by Dr. Azadi, more than 55% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 115 general payments to Dr. Azadi from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Medtronic, Inc. paid the most, $693.

Dr. Azadi graduated from VCU School of Medicine in 2007. Dr. Azadi is a member of ACC.

Dr. Azadi is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.